Trials / Active Not Recruiting
Active Not RecruitingNCT06415175
Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
Prospective, Observational, Longitudinal Study in Paediatric Patients With AD, Treated With Dupilumab in Spain
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 143 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 6 Months – 11 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicentre, prospective, non-interventional study that aims to describe the treatment patterns of in Atopic dermatitis (AD) patients aged 6 months to 11 years old in Spain: patients' characteristics, disease characteristics, prior treatments for and treatment prescription modalities. As well as to document the real-world effectiveness and safety of dupilumab during the two years of follow up. No diagnostic or therapeutic intervention outside of routine clinical practice will be applied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dupilumab | This study will not administer any treatment, only observe the treatment as prescribed in real world-clinical practice. |
Timeline
- Start date
- 2024-11-14
- Primary completion
- 2026-09-30
- Completion
- 2027-11-23
- First posted
- 2024-05-16
- Last updated
- 2026-02-25
Locations
15 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT06415175. Inclusion in this directory is not an endorsement.